Japan, Nov. 17 -- ASTELLAS PHARMA EUROPE LTD has got intellectual property rights for 'NOVEL DOSAGE REGIMEN OF TIACUMICIN COMPOUND.' Other related details are as follows:
Application Number: JP,2021-133778
Category (FI): A61P1/12,A61P31/04,A61K31/7048,C07H17/08@K
Stage: Grant (IP right granted following substantive examination.)
Filing Date: Aug. 19, 2021
Publication Date: Dec. 23, 2021
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
